MIRA ▲ +1.8% - MIRA Pharmaceuticals, Inc.
$MIRA - MIRA Pharmaceuticals Reports Significant Weight and Fat Reduction With Oral SKNY-1 in Obese Mice, Showing Favorable Lean-Mass and Weight-Regain Outcomes Compared With Semaglutide
29-OCT-2026 08:00 AM ET
Share this post
More filings for $MIRA
View full $MIRA filing history →💬 Comments
Loading comments…
Leave a comment
